Next, we characterized the immune infiltration patterns in high and low expression FLI1 subtypes of BRCA patients by using the immune infiltration levels of 28 immune cell types, immune‐related features and expression level of immunomodulators such as PD‐1, PD‐L1 and CTLA‐4. The gene discussed is FLI1; the disease is invasive breast carcinoma.